Примери за използване на It be given marketing authorisation на Английски и техните преводи на Български
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Computer
NovoThirteen's benefits are greater than its risks and recommended that it be given marketing authorisation.
Based on the assessment performed by the CAT, the CHMP decided that ChondroCelect's benefits are greater than its risks and recommended that it be given marketing authorisation.
The CHMP concluded that the benefits of Champix outweigh its risks and recommended that it be given marketing authorisation.
The CHMP concluded that the benefits of EndolucinBeta outweigh the risks and recommended that it be given marketing authorisation.
The CHMP decided that Vpriv's benefits are greater than its risks and recommended that it be given marketing authorisation.
The CHMP decided that Clopidogrel Zentiva's benefits are greater than its risks and recommended that it be given marketing authorisation.
CHMP decided that Janumet's benefits are greater than its risks and recommended that it be given marketing authorisation.
The CHMP decided that Possia's benefits are greater than its risks and recommended that it be given marketing authorisation.
The CHMP decided that Ebixa's benefits are greater than its risks and recommended that it be given marketing authorisation.
The Agency concluded that Truvada's benefits are greater than its risks and recommended that it be given marketing authorisation.
The Committee decided that the benefits of Icandra are greater than its risks and recommended that it be given marketing authorisation.
The Committee decided that Savene's benefits are greater than its risks and recommended that it be given marketing authorisation.
The CHMP decided that Imprida's benefits are greater than its risks and recommended that it be given marketing authorisation.
The CHMP therefore decided that the benefits of Sprimeo are greater than its risks and recommended that it be given marketing authorisation.
Therefore, the CHMP decided that Eklira Genuair's benefits are greater than its risks and recommended that it be given marketing authorisation.
Therefore, the CHMP concluded that Flebogamma DIF's benefits are greater than its risks and recommended that it be given marketing authorisation.
The Committee for Medicinal Products for Human Use(CHMP)decided that IntronA's benefits are greater than its risks and recommended that it be given marketing authorisation.
The Committee for Medicinal Products for Human Use(CHMP)decided that Apidra's benefits are greater than its risks and recommended that it be given marketing authorisation.